Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1756-9966
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression ; volume:40 ; number:1 ; day:26 ; month:6 ; year:2021 ; pages:1-19 ; date:12.2021
Journal of experimental & clinical cancer research ; 40, Heft 1 (26.6.2021), 1-19, 12.2021

Creator
Kemper, Marius
Schiecke, Alina
Maar, Hanna
Nikulin, Sergey
Poloznikov, Andrey
Galatenko, Vladimir
Tachezy, Michael
Gebauer, Florian
Lange, Tobias
Riecken, Kristoffer
Tonevitsky, Alexander
Aigner, Achim
Izbicki, Jakob
Schumacher, Udo
Wicklein, Daniel
Contributor
SpringerLink (Online service)

DOI
10.1186/s13046-021-01946-2
URN
urn:nbn:de:101:1-2021101006553925509302
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:33 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Kemper, Marius
  • Schiecke, Alina
  • Maar, Hanna
  • Nikulin, Sergey
  • Poloznikov, Andrey
  • Galatenko, Vladimir
  • Tachezy, Michael
  • Gebauer, Florian
  • Lange, Tobias
  • Riecken, Kristoffer
  • Tonevitsky, Alexander
  • Aigner, Achim
  • Izbicki, Jakob
  • Schumacher, Udo
  • Wicklein, Daniel
  • SpringerLink (Online service)

Other Objects (12)

[Beta]6-integrin serves as a potential serum marker for diagnosis and prognosis of pancreatic adenocarcinoma

[Beta]6-integrin serves as a potential serum marker for diagnosis and prognosis of pancreatic adenocarcinoma

β8 integrin regulates pancreatic cancer cell radiochemoresistance

β8 integrin regulates pancreatic cancer cell radiochemoresistance

The αvβ6 integrin specific virotherapy, Ad5NULL-A20.FCU1, selectively delivers potent “in-tumour” chemotherapy to pancreatic ductal adenocarcinoma

The αvβ6 integrin specific virotherapy, Ad5NULL-A20.FCU1, selectively delivers potent “in-tumour” chemotherapy to pancreatic ductal adenocarcinoma

Models of pancreatic ductal adenocarcinoma

Models of pancreatic ductal adenocarcinoma

Novel tumor suppressors in pancreatic adenocarcinoma

Hochschulschrift

Novel tumor suppressors in pancreatic adenocarcinoma

Advanced pancreatic ductal adenocarcinoma : moving forward

Advanced pancreatic ductal adenocarcinoma : moving forward

Apoptotic pathways in pancreatic ductal adenocarcinoma

Apoptotic pathways in pancreatic ductal adenocarcinoma

Oral mycobiota and pancreatic ductal adenocarcinoma

Oral mycobiota and pancreatic ductal adenocarcinoma

Ferroptosis as an important driver of lupus

Ferroptosis as an important driver of lupus

Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinoma

Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinoma

A porcine model of pancreatic ductal adenocarcinoma

A porcine model of pancreatic ductal adenocarcinoma

Orthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma

Orthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma

Related objects